Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The term Multiple cellular and molecular processes does not refer to a specific, individual molecular target such as a receptor, enzyme, or ion channel. In pharmacological research, a drug target is strictly defined as a discrete biological entity, usually a protein, whose activity can be modified by an external agent to achieve a therapeutic outcome (Source: Nature Reviews Drug Discovery, https://www.nature.com/articles/nrd.2017.230). This phrase is instead a broad descriptor used to characterize the pleiotropic effects of a drug or the complex physiological responses involving numerous simultaneous signaling pathways (Source: NIH, https://www.ncbi.nlm.nih.gov/books/NBK27902/). Because it encompasses a vast array of unrelated biological activities, it lacks the specificity required for modern drug discovery, which relies on identifying precise molecular interactions. Consequently, this entry is classified as incorrect for structured target databases as it represents 'too much information' or a lack of a defined molecular identity.
Not applicable as this is a descriptive category rather than a specific molecular target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Multiple cellular and molecular processes.